Marinus Pharmaceuticals Inc (MRNS)
1.51
+0.06
(+4.14%)
USD |
NASDAQ |
May 03, 16:00
1.515
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Research and Development Expense (Quarterly): 26.38M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.38M |
| September 30, 2023 | 23.66M |
| June 30, 2023 | 21.41M |
| March 31, 2023 | 27.93M |
| December 31, 2022 | 21.42M |
| September 30, 2022 | 19.00M |
| June 30, 2022 | 21.50M |
| March 31, 2022 | 17.99M |
| December 31, 2021 | 18.01M |
| September 30, 2021 | 18.35M |
| June 30, 2021 | 18.56M |
| March 31, 2021 | 18.59M |
| December 31, 2020 | 13.04M |
| September 30, 2020 | 11.31M |
| June 30, 2020 | 11.75M |
| March 31, 2020 | 15.00M |
| December 31, 2019 | 12.51M |
| September 30, 2019 | 11.57M |
| June 30, 2019 | 10.01M |
| March 31, 2019 | 8.872M |
| December 31, 2018 | 8.087M |
| September 30, 2018 | 9.148M |
| Date | Value |
|---|---|
| June 30, 2018 | 7.232M |
| March 31, 2018 | 3.927M |
| December 31, 2017 | 3.344M |
| September 30, 2017 | 2.642M |
| June 30, 2017 | 2.817M |
| March 31, 2017 | 3.573M |
| December 31, 2016 | 4.412M |
| September 30, 2016 | 4.84M |
| June 30, 2016 | 7.258M |
| March 31, 2016 | 5.494M |
| December 31, 2015 | 6.06M |
| September 30, 2015 | 3.472M |
| June 30, 2015 | 3.915M |
| March 31, 2015 | 5.468M |
| December 31, 2014 | 2.152M |
| September 30, 2014 | 1.569M |
| June 30, 2014 | 2.805M |
| March 31, 2014 | 2.149M |
| December 31, 2013 | 1.129M |
| September 30, 2013 | 1.008M |
| June 30, 2013 | 1.327M |
| March 31, 2013 | 0.7473M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
10.01M
Minimum
Jun 2019
27.93M
Maximum
Mar 2023
17.79M
Average
18.35M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 5.488M |
| Soligenix Inc | 0.7775M |
| Actinium Pharmaceuticals Inc | 6.635M |
| Macrogenics Inc | 47.35M |
| ADMA Biologics Inc | 0.4455M |